Sabra Health Care REIT Inc (NASDAQ:SBRA) – Equities research analysts at Jefferies Group cut their FY2018 earnings per share (EPS) estimates for shares of Sabra Health Care REIT in a report released on Tuesday. Jefferies Group analyst O. Okusanya now expects that the real estate investment trust will post earnings of $2.27 per share for the year, down from their previous forecast of $2.32. Jefferies Group currently has a “Hold” rating on the stock. Jefferies Group also issued estimates for Sabra Health Care REIT’s FY2019 earnings at $2.23 EPS.
Several other research analysts have also commented on SBRA. Zacks Investment Research lowered Sabra Health Care REIT from a “hold” rating to a “sell” rating in a report on Wednesday, January 10th. Cantor Fitzgerald reissued a “buy” rating and set a $30.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, September 28th. ValuEngine lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. TheStreet lowered Sabra Health Care REIT from a “b-” rating to a “c” rating in a research note on Friday, November 3rd. Finally, Capital One Financial started coverage on Sabra Health Care REIT in a research note on Monday, September 25th. They issued an “equal weight” rating and a $24.00 target price for the company. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $24.40.
Shares of Sabra Health Care REIT (NASDAQ SBRA) traded up $0.01 during midday trading on Wednesday, hitting $17.93. The stock had a trading volume of 1,294,400 shares, compared to its average volume of 1,506,964. Sabra Health Care REIT has a 52 week low of $17.76 and a 52 week high of $29.10. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.89. The stock has a market capitalization of $3,140.00, a price-to-earnings ratio of 22.99, a price-to-earnings-growth ratio of 2.44 and a beta of 0.93.
Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, November 1st. The real estate investment trust reported $0.11 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.68 by ($0.57). Sabra Health Care REIT had a return on equity of 4.86% and a net margin of 25.79%.
In other Sabra Health Care REIT news, Director Milton J. Walters sold 4,615 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $19.18, for a total value of $88,515.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.60% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently modified their holdings of SBRA. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Sabra Health Care REIT by 9.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,151 shares of the real estate investment trust’s stock valued at $100,000 after purchasing an additional 352 shares during the period. Riverhead Capital Management LLC boosted its stake in shares of Sabra Health Care REIT by 96.0% during the second quarter. Riverhead Capital Management LLC now owns 6,861 shares of the real estate investment trust’s stock valued at $165,000 after purchasing an additional 3,361 shares during the period. Flinton Capital Management LLC boosted its stake in shares of Sabra Health Care REIT by 96.1% during the second quarter. Flinton Capital Management LLC now owns 6,868 shares of the real estate investment trust’s stock valued at $165,000 after purchasing an additional 3,366 shares during the period. FNY Partners Fund LP purchased a new stake in shares of Sabra Health Care REIT during the third quarter valued at approximately $155,000. Finally, Laurion Capital Management LP purchased a new stake in shares of Sabra Health Care REIT during the second quarter valued at approximately $200,000. 85.47% of the stock is owned by institutional investors and hedge funds.
WARNING: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/18/fy2018-earnings-estimate-for-sabra-health-care-reit-inc-sbra-issued-by-jefferies-group.html.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.